Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

494
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
494
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

422
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
422
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

370
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
370
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

798
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
798
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

730
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
730
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

243
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
243

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Normal standardized left ventricular longitudinal strain curves stratified by age and sex in healthy individuals: The Copenhagen City Heart Study.

European heart journal. Cardiovascular Imaging·2026
Same author

GLP-1 receptor agonists in patients with Type 2 diabetes: cardiorenal protection versus ocular safety.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.

Diabetes, obesity & metabolism·2026
Same author

Inter-arm Blood Pressure Difference is Associated With Both Coronary Artery Disease and Peripheral Artery Disease in People With HIV.

Open forum infectious diseases·2026
Same author

Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.

Diabetes care·2026
Same author

Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Nephrology in the Paradigm of Cardiovascular-Kidney-Metabolic Health: Report of an ASN Initiative on Saving Kidneys, Hearts, and Lives.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

Genetic Risk Factors for Kidney Function in Individuals with Type 1 Diabetes.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

How I Treat a Patient with Primary Aldosteronism.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

Major Adverse Kidney Events in the American Indian or Alaska Native Population with Diabetes.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

Atrial Fibrillation and Stroke Prevention and Management in Chronic Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

A Framework for Risk-Based Implementation of Combination Therapy in CKD: Who, Why, When, and How?

Clinical journal of the American Society of Nephrology : CJASN·2026
関連記事をすべて見る

関連する実験動画

Updated: Feb 19, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K

慢性腎臓病患者における労働力離職

Rasmus Rørth1, Milos M Koch2, Thomas A Gerds1,2

  • 1Steno Diabetes Center Copenhagen, Copenhagen, Denmark.

Clinical journal of the American Society of Nephrology : CJASN
|February 17, 2026
PubMed
まとめ
この要約は機械生成です。

慢性腎臓病 (CKD) の個人は,労働力から離脱するリスクが著しく高い. CKDの早期発見と治療介入は,この影響を軽減するために不可欠です.

さらに関連する動画

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.1K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.8K

関連する実験動画

Last Updated: Feb 19, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.1K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.8K

科学分野:

  • ネフロロジーはネフロロジーを用います.
  • 公衆衛生は公衆衛生である.
  • 職業医学は職業医学である.

背景:

  • 腎臓機能障害は,死亡率や生活の質の低下を含む健康への悪影響と関連しています.
  • 雇用の状態は,金融の安定,健康,個人のアイデンティティと密接に結びついています.
  • 腎機能と労働力参加の関係については,さらなる調査が必要である.

研究 の 目的:

  • 慢性腎臓病 (CKD) ステータスとCKDステージと労働力の離職との関連を調べる.
  • CKDを有する労働年齢人口における労働力の離職の絶対的リスクを推定する.

主な方法:

  • 毎週更新される職業状態のデータを,検査結果と国家登録簿と組み合わせて利用した.
  • 労働年齢人口 (18-60歳) の推定腎臓機能.
  • 退職と死亡の競合するリスクを考慮するために,アレン-ヨハンセン推定器を使用しました.

主要な成果:

  • CKDを有する個人は,労働力の離職の絶対的なリスクがより高かった (1年リスク:9%対5%,p<0.001).
  • 労働力の離職のリスクは,CKDの重症度によって増加し,5% (eGFR>60) から20% (CKDステージG5) に及ぶ.
  • 高齢,女性の性別,糖尿病,低教育水準などの要因は,労働力の脱離の増加と関連していました.

結論:

  • CKDは,正常な腎機能と比較して,労働力の脱離の可能性を大幅に増加させます.
  • これは,CKDの認識されていない負担を強調しています.
  • CKDの早期発見と治療介入の緊急の必要性が強調されています.